MUC-1 cytoplasmic domain peptides as inhibitors of cancer

Details for Australian Patent Application No. 2009305550 (hide)

Owner Dana-Farber Cancer Institute, Inc. Genus Oncology, LLC

Inventors Kufe, Donald W.; Kharbanda, Surender

Agent Pizzeys

Pub. Number AU-A-2009305550

PCT Pub. Number WO2010/045586

Priority 61/106,380 17.10.08 US; 61/177,109 11.05.09 US

Filing date 16 October 2009

Wipo publication date 22 April 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 35/00 (2006.01) Antineoplastic agents

C07K 7/64 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

19 May 2011 PCT application entered the National Phase

  PCT publication WO2010/045586 Priority application(s): WO2010/045586

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009305563-Pharmaceutical compositions with attenuated release of phenolic opioids

2009305532-Methods of obtaining cell populations from adipose tissue